Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sharp Appoints New Clinical Leadership | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Sharp Appoints New Clinical Leadership

Robert Feltz and Michael MacNeir appointed to Sharp leadership team.

By: Maria Gervino

, Rodman Media Happi Magazine

Sharp, a provider of pharmaceutical packaging and clinical services, has strengthened their clinical leadership team with the appointment of Robert Feltz as director of analytical and formulation services and Michael MacNeir as vice president, global business development.

Feltz has over 15 years of industry experience and moves to Sharp from Altasciences, where he was director of analytical services. He oversaw multiple drug candidates from pre-clinical to commercial launch. 

MacNeir joins Sharp from Marken, where he was vice president of commercial operations for the Americas. He brings over 14 years of clinical trial supply and operational experience.

“I am delighted to welcome Robert Feltz and Michael MacNeir to Sharp and I am confident they will make a significant contribution in shaping and growing our clinical business,“ said Robert O’Beirn, managing director of Sharp Clinical. “Their respective industry expertise will put us in a stronger position to deliver and expand our client-led clinical solutions, to better serve our customers and their patients.”

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics